Core Viewpoint - Sitka Gold Corp. has appointed Gilles Dessureau as Vice President of Exploration, succeeding Greg Dawson, who will transition to Senior Technical Advisor. The company is also enhancing its technical advisory team with the addition of Brad Thrall as a metallurgical advisor [1][4][8]. Group 1: Leadership Changes - Gilles Dessureau has been promoted from Senior Project Manager at the RC Gold Project to Vice President of Exploration, bringing over 20 years of experience in mineral exploration [2][4]. - Greg Dawson will remain a Director and take on the role of Senior Technical Advisor, continuing to provide oversight on exploration programs [6][7]. Group 2: Project Highlights - The RC Gold Project has a mineral resource estimate of 1.3 million ounces of gold indicated and 1.5 million ounces inferred, supported by a technical report prepared in accordance with NI 43-101 standards [2][3]. - The project consists of a 431 square kilometer land package located in Yukon's Tombstone Gold Belt, strategically positioned between the Eagle Gold Mine and the Brewery Creek Gold Mine [9]. Group 3: Technical Advisory Team - Brad Thrall, with over 35 years of experience in metallurgical engineering, joins the technical advisory team, bringing expertise from his previous roles, including co-founder and President of Alexco Resource Corp. [8][9]. - Thrall's experience with Yukon projects will aid in guiding metallurgical studies for the RC Gold Project [9]. Group 4: Exploration and Development - The RC Gold Project has two main zones: Blackjack and Eiger, with significant gold resources that are potentially open pit minable and amenable to heap leaching [10][11]. - A planned 30,000-meter diamond drilling program for 2025 is currently underway at the RC Gold Project [13].

Core Insights - Tevogen Bio aims to set new efficiency standards in the biotech industry, focusing on innovation and cost-effectiveness amidst rising drug development costs [1][2] - The company is leveraging CD8+ cytotoxic T lymphocytes to develop precision T cell therapies for infectious diseases and cancers, addressing significant unmet medical needs [3] - Tevogen Bio's leadership emphasizes the importance of sustainability and patient accessibility through advanced science and innovative business models [3][4] Company Overview - Tevogen Bio is a clinical-stage specialty immunotherapy company that develops off-the-shelf, genetically unmodified precision T cell therapies [3] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents [3] - Tevogen Bio's leadership team consists of experienced industry leaders and scientists with a focus on accessible personalized therapeutics [4] Market Position - Tevogen Bio has a market capitalization per team member that is 600% higher than the industry average, indicating strong market positioning [7] - The current ownership breakdown shows that insiders hold 79% of the company, with a significant lead investor and SPAC sponsor involvement [7] - The company's assets are believed to be valued in the billions, although these are not reflected on the balance sheet due to accounting regulations [7]

Core Insights - Dime Community Bancshares, Inc. announced the appointment of Thomas X. Geisel as Senior Executive Vice President of Commercial Lending, aimed at enhancing and diversifying its commercial lending business [1][2] - The company has experienced significant growth in core deposits and business loans over the past two years, leveraging market disruptions and talent acquisition [2] - Geisel brings over twenty years of leadership experience in regional banks, having previously transformed Sterling National Bank into a $30 billion institution [2] Company Overview - Dime Community Bancshares, Inc. is the parent company of Dime Community Bank, which has over $14 billion in assets and holds the number one deposit market share among community banks in Greater Long Island [3]

Core Insights - SpringWorks Therapeutics is collaborating with Jennifer Fisher to raise awareness about desmoid tumors and encourage patients to seek specialized care [1][3][4] Company Overview - SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, having developed the first FDA-approved therapy for adults with progressing desmoid tumors [6][7] Industry Context - Desmoid tumors are rare, aggressive, and locally invasive soft tissue tumors, with an estimated 1,000-1,650 new cases diagnosed annually in the United States [5][6] - The tumors have a high recurrence rate of up to 77% after surgical resection, leading to a shift in treatment guidelines recommending systemic therapies as the first-line intervention [5][6]

Core Insights - WELL Health Technologies Corp. is enhancing its digital healthcare capabilities through its subsidiary WELLSTAR Technologies Corp., which is set to become a separate public company majority-owned by WELL [1][2] - Recent management additions include Sarah Xu as Vice President of Growth Operations and Frank Seiferth as Vice President of Product, both bringing extensive industry experience [5][11] - WELLSTAR has acquired Microquest and Bluebird iT, expanding its technology solutions and market presence in Canada [2][3] Management Team Updates - Sarah Xu has a strong background in growth strategy and healthcare technology, previously working at Google and Ambience Healthcare, and is expected to drive WELLSTAR's market presence and growth initiatives [7][10] - Frank Seiferth has over 25 years of experience in product leadership across various sectors, including health-tech, and will lead product strategy at WELLSTAR [11][13] Acquisitions and Market Position - WELLSTAR's acquisition of Microquest, which serves 375 clinics and 1,600 providers in Alberta, and Bluebird iT, the largest IT service provider for outpatient clinics in Canada, enhances its service offerings [2][5] - With these acquisitions, WELLSTAR now serves over 40% of all physicians in Canada and has a team of over 330 members [4][5] Technology Solutions and Services - WELLSTAR provides a comprehensive suite of technology solutions, including EMR software, digital health apps, and AI-enabled automation tools, aimed at improving operational efficiency and patient care [16] - The company focuses on reducing administrative burdens for healthcare providers through innovative digital solutions [4][16]

Core Viewpoint - Matthews International Corporation urges shareholders to vote for its three director nominees, emphasizing that failure to do so will lead to short-term oversight by individuals lacking knowledge of the company's businesses [1][2]. Strategic Initiatives - The company has initiated a strategic alternatives process that has already resulted in the sale of SGK Brands Solutions for $350 million and a 40% equity stake in a new joint venture, with an additional $50 million expected from the sale of remaining operating businesses [1]. - Matthews plans to announce several strategic initiatives in 2025 aimed at enhancing shareholder value [1]. Energy Storage Solutions - Matthews has developed innovative dry battery electrode (DBE) solutions to capitalize on the growing energy storage market and has successfully defended its ownership against Tesla [1]. - The company is now positioned to sell its DBE solutions to various customers in the electric vehicle market following favorable arbitration outcomes [1]. Board Composition and Governance - The company has refreshed its Board to align with its strategic focus, appointing Thomas Gebhardt, who has over 30 years of experience in battery and EV technology [1]. - Recent governance enhancements include a Board Chair transition and proposals to declassify the Board, aimed at creating sustainable long-term shareholder value [1]. Shareholder Support - GAMCO Asset Management, a significant shareholder with a 4.38% stake, has expressed support for Matthews' director nominees, believing they are best positioned to drive value for shareholders [3]. Voting Instructions - Shareholders are encouraged to vote "FOR" Matthews' nominees using the WHITE proxy card and "WITHHOLD" on Barington's nominees [4][6].

Meta is reportedly forming a new team that will be devoted to developing artificial intelligence-powered humanoid robots.The team will be within the company’s Reality Labs hardware division, Bloomberg reported Friday (Feb. 14), citing unnamed sources. It will be led by Marc Whitten, the former CEO of General Motors’ Cruise self-driving division, and will add about 100 engineers this year.Meta did not immediately reply to PYMNTS’ request for comment.The company plans to work on its own humanoid robot hardwar ...

Boise, Idaho--(Newsfile Corp. - February 11, 2025) - Thunder Mountain Gold, Inc. (OTCQB: THMG) (TSXV: THM) (the "Company" or "Thunder Mountain Gold") is pleased to announce the appointment of Ron Espell as Chief Operating Officer (COO) and Rocky Chase as Vice President of Operations, effective immediately. These appointments reflect the Company's commitment to advancing its South Mountain Project and other strategic initiatives with a leadership team that brings deep operational and environmental expertise ...

WARREN, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, met the Center for the Biomedical Advanced Research and Development Authority (BARDA) TechWatch team. The discussion focused on Tevogen Bio’s affordable and scalable ExacTcell technology, the positive results of its proof-of-concept (POC) clinical trial for TVGN 489, the use of Artificial Intelligence in its process and future manufa ...

EXTON, Pa., Jan. 29, 2025 /PRNewswire/ -- First Resource Bancorp, Inc. (OTCQX: FRSB), the holding company for First Resource Bank, is proud to welcome Jim Egan as Senior Vice President of Commercial Lending. With an impressive career spanning 40 years in the banking industry—38 of which were spent at Bryn Mawr Trust, where he served as Chief Commercial Lending Officer and Head of Commercial Real Estate—Jim brings unparalleled expertise and a deep understanding of commercial lending to his new role. Jim ...